Avanos Medical Inc (AVNS) reports solid revenue and EBITDA growth, while addressing supply issues and strategic ...

Q3 2024 Earnings Call Transcript October 30, 2024 Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $ EPS ...

Net income: US$5.90m (up from US$8.80m loss in 3Q 2023). Profit margin: 3.5% (up from net loss in 3Q 2023). EPS: US$0.13 (up from US$0.19 loss in 3Q 2023).

Avanos Medical, Inc. (NYSE:AVNS), a healthcare company specializing in medical devices and equipment, is navigating a complex landscape of transformation initiatives and market challenges. The company ...

Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter ... which was affected by transient execution and supply issues stemming from backorder challenges ...

Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 ...

Avanos Medical, Inc. (NYSE ... Uncertainty around revenue growth for ON-Q due to past supply constraints and pending reimbursement rates. New direct-to-consumer strategies for Game Ready and ...

Medical-device maker Avanos Medical named Chief Financial Officer Michael Greiner interim chief executive, taking the reins from veteran Joe Woody, as the company also posted a down-tick in ...